Also trades as: STX.L (LSE) · $vol 0M
SHIEF OTC
Shield Therapeutics plc
1W: +0.0%
1M: +21.6%
3M: +7.0%
YTD: -41.4%
1Y: -15.8%
3Y: -13.5%
5Y: -93.7%
$0.09
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$32M
+145.9% ▲
5Y CAGR: +113.9%
Gross Profit
$15M
+270.7% ▲
5Y CAGR: +129.6%
Operating Income
-$23M
+27.0% ▲
Net Income
-$27M
+18.4% ▲
EPS (Diluted)
$-0.03
+34.9% ▲
EBITDA
-$21M
+29.8% ▲
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| Revenue | $10M | $2M | $5M | $13M | $32M |
| YoY Growth | +1344.6% | -85.4% | +199.5% | +187.7% | +145.9% |
| Cost of Revenue | $1M | $980K | $3M | $9M | $17M |
| Gross Profit | $9M | $539K | $2M | $4M | $15M |
| Gross Margin | 87.0% | 35.5% | 44.7% | 30.8% | 46.4% |
| R&D Expenses | $3M | $579K | $1M | $2M | $2M |
| SG&A Expenses | $8M | $20M | $31M | $37M | $35M |
| Operating Expenses | $11M | $21M | $43M | $35M | $38M |
| Operating Income | -$2M | -$20M | -$41M | -$31M | -$23M |
| Operating Margin | -20.7% | -1336.0% | -904.7% | -239.4% | -71.1% |
| Interest Expense | $1K | $11K | $404K | $1M | $4M |
| Income Before Tax | -$3M | -$20M | -$41M | -$32M | -$27M |
| Tax Expense | $1M | -$229K | $369K | $918K | $626K |
| Net Income | -$4M | -$20M | -$50M | -$33M | -$27M |
| Net Margin | -34.5% | -1295.5% | -1094.5% | -254.4% | -84.5% |
| EPS (Diluted) | $-0.02 | $-0.09 | $-0.21 | $-0.05 | $-0.03 |
| EBITDA | $1M | -$19M | -$25M | -$30M | -$21M |
| Shares Outstanding | 124M | 210M | 238M | 723M | 906M |